Article
Current and Novel Inhibitors of HIV Protease
11 Dec 2009
Abstract excerpt
The design, development and clinical success of HIV protease inhibitors represent one of the most remarkable achievements of molecular medicine. This review describes all nine currently available FDA-approved protease inhibitors, discusses their pharmacokinetic properties, off-target activities, side-effects, and resistance profiles. The compounds in the various stages of clinical development are also introduced,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
